This suggests that the molecular mechanism of the muscular dystrophy caused by JAG2 mutations overlaps with that underlying EMARDD, and also argues for JAG2 as a putative gene modifier in MEGF10-myopathy. The gene discussed is MEGF10; the disease is MEGF10-related myopathy.